Erythromycin B (CAS 527-75-3)

Erythromycin B is a macrocyclic compound and a minor constituent of the erythromycin complex, derived from the fermentation of the bacterium Saccharopolyspora erythraea. Structurally similar to its more prominent counterpart, erythromycin A, erythromycin B features a macrocyclic lactone ring with sugars desosamine and cladinose attached, which are crucial for its bioactivity. The primary mode of action of erythromycin B involves the inhibition of bacterial protein synthesis. It achieves this by binding to the 50S subunit of the bacterial ribosome, thereby blocking the exit tunnel used by the growing peptide chain. This interaction effectively halts the translation process, preventing the assembly of proteins essential for bacterial growth and replication. In research, erythromycin B has been used to study ribosomal structure and function, offering insights into the complex mechanisms of protein synthesis and the role of antibiotics in inhibiting this process. These studies are essential for understanding how ribosomal inhibitors influence bacterial physiology and for the exploration of ribosome-targeting antibiotics. Additionally, erythromycin B serves as a reference molecule in biochemical experiments designed to decipher the nuances of antibiotic action and resistance mechanisms in pathogenic bacteria, thereby contributing to the foundational knowledge in microbial biochemistry.